CJ Bioscience Inc
311690
Company Profile
Business description
CJ Bioscience Inc is engaged in directing a healthy life based on microbiological research. It presents directions and solutions to all fields of research on the microbiome, such as academia in the bioinformatics field, R&D centers of hospitals and research institutes, and NGS (next-generation sequencing) service companies. Its services includes NGS, EZBioCloud, Healthcare among others.
Contact
7th floor, Grand Central Building B
14 Sejong-Daero
Jung-gu
Seoul
KORT: +82 260783456
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
124
Stocks News & Analysis
stocks
ASX healthcare share remains undervalued ahead of earnings
Margin recovery remains the key driver for this ASX healthcare share.
stocks
Alphabet earnings: Strong AI monetization continues to spearhead results
We maintain our fair value estimate for wide-moat Alphabet.
stocks
AMD: We’re pleased with Anthropic Partnership ahead of advancing AI event
We’re encouraged that AMD will count Anthropic as a third leading AI customer, in addition to OpenAI and Meta.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,941.50 | 32.70 | -0.36% |
| CAC 40 | 8,290.17 | 8.92 | -0.11% |
| DAX 40 | 24,829.40 | 66.28 | 0.27% |
| Dow JONES (US) | 51,711.65 | 506.93 | -0.97% |
| FTSE 100 | 10,625.41 | 13.76 | -0.13% |
| HKSE | 24,855.52 | 355.29 | -1.41% |
| NASDAQ | 25,137.69 | 553.21 | -2.15% |
| Nikkei 225 | 64,611.15 | 1,811.45 | -2.73% |
| NZX 50 Index | 13,772.29 | 23.02 | -0.17% |
| S&P 500 | 7,408.30 | 90.66 | -1.21% |
| S&P/ASX 200 | 8,772.30 | 23.40 | -0.27% |
| SSE Composite Index | 3,814.20 | 62.58 | -1.61% |